Cargando…
Vitamin in the Crosshairs: Targeting Pantothenate and Coenzyme A Biosynthesis for New Antituberculosis Agents
Despite decades of dedicated research, there remains a dire need for new drugs against tuberculosis (TB). Current therapies are generations old and problematic. Resistance to these existing therapies results in an ever-increasing burden of patients with disease that is difficult or impossible to tre...
Autores principales: | Butman, Hailey S., Kotzé, Timothy J., Dowd, Cynthia S., Strauss, Erick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7770189/ https://www.ncbi.nlm.nih.gov/pubmed/33384970 http://dx.doi.org/10.3389/fcimb.2020.605662 |
Ejemplares similares
-
Characterization of Plasmodium falciparum Pantothenate Kinase and Identification of Its Inhibitors From Natural Products
por: Nurkanto, Arif, et al.
Publicado: (2021) -
Antituberculosis Therapy and Gut Microbiota: Review of Potential Host Microbiota Directed-Therapies
por: Diallo, Dramane, et al.
Publicado: (2021) -
Structural Dynamics and Perspectives of Vitamin B6 Biosynthesis Enzymes in Plasmodium: Advances and Open Questions
por: Barra, Angélica Luana C., et al.
Publicado: (2021) -
Tremor Drugs in the Crosshairs
por: Lagrand, Tjerk J., et al.
Publicado: (2021) -
Evaluating the Genetic Capacity of Mycoplasmas for Coenzyme A Biosynthesis in a Search for New Anti-mycoplasma Targets
por: Ras, Tertius Alwyn, et al.
Publicado: (2021)